Ceftazidime therapy in patients with cystic fibrosis and multiply-drug-resistant pseudomonas
- 9 August 1985
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 79 (2) , 37-46
- https://doi.org/10.1016/0002-9343(85)90259-1
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Imipenem/Cilastatin in Acute Pulmonary Exacerbations of Cystic FibrosisClinical Infectious Diseases, 1985
- Infections Caused by Pseudomonas aeruginosaClinical Infectious Diseases, 1983
- Pharmacokinetics of tobramycin in cystic fibrosisThe Journal of Pediatrics, 1982
- Dosing implications of altered gentamicin disposition in patients with cystic fibrosisThe Journal of Pediatrics, 1982
- Comparison of in vitro activity of GR 20263, a novel cephalosporin derivative, with activities of other beta-lactam compoundsAntimicrobial Agents and Chemotherapy, 1980
- GR 20263, a new broad-spectrum cephalosporin with anti-pseudomonal activityAntimicrobial Agents and Chemotherapy, 1980
- Pharmacokinetics of Methicillin in Patients with Cystic FibrosisThe Journal of Infectious Diseases, 1977
- Bacterial Infection in Cystic FibrosisArchives of Disease in Childhood, 1972
- A genetic study of fibrocystic disease of the pancreasAnnals of Human Genetics, 1965
- The flora of the respiratory tract of patients with cystic fibrosis of the pancreasThe Journal of Pediatrics, 1961